LogicBio Therapeutics, Inc. Company Profile

07:25 EST 16th December 2018 | BioPortfolio

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for life-threatening diseases. Its GeneRide™ technology enables highly specific genome editing and integration of the therapeutic transgene, utilizing the body's own native processes to drive durable expression. LogicBio is initially targeting a wide range of diseases not addressable today, including early-onset conditions in young patients. With a world-class global team headquartered in Cambridge, Massachusetts, LogicBio is working to deliver the next wave of innovation in genetic medicine.

News Articles [704 Associated News Articles listed on BioPortfolio]

LogicBio Jumps on the Gene Therapy 2.0 Wave and Lines Up an IPO

Another gene therapy company is on its way to the public markets. But this one, LogicBio Therapeutics, is part of a newer crop of gene therapy developers that aim to overcome the potential shortcoming...

LogicBio seeks to raise $86M in IPO

An initial public offering was filed by LogicBio Therapeutics, a gene therapy company, seeking to raise $86 million.  -More- 

Series A brings $4.4mm to LogicBio; $444k added

LogicBio Therapeutics Inc. raised $4.4mm through its Series A round from OrbiMed Advisors and Leland Stanford Junior University. The company is developing gene therapies for pediatric liver diseases. ...

LogicBio's initial public offering nets $74.9mm

LogicBio Therapeutics Inc. (gene editing) netted $74.9mm through its initial public offering of 8mm common shares (including the overallotment) at $10. The company originally intended to sell 5.77mm s...

LogicBio files for initial public offering

LogicBio Therapeutics Inc. (gene editing) filed for its initial public offering.

LogicBio Prices IPO Below Range, Raising $70M to Test Gene Therapy

LogicBio Therapeutics has joined the list of biotechs to go public this year but it had to cut the price of its IPO and sell more shares to pull it off. The Cambridge, MA, biotech priced its offering ...

LogicBio Therapeutics Starts U.S. IPO Process

Arix Bioscience pours another £5.4mln into LogicBio as investee company lists on Nasdaq

As a result of the IPO, the value of Arix’s stake in LogicBio has soared to almost £23mln, including the extra investment announced today

PubMed Articles [460 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1286 Associated Companies listed on BioPortfolio]

LogicBio Therapeutics, Inc.

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "LogicBio Therapeutics, Inc." on BioPortfolio

We have published hundreds of LogicBio Therapeutics, Inc. news stories on BioPortfolio along with dozens of LogicBio Therapeutics, Inc. Clinical Trials and PubMed Articles about LogicBio Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LogicBio Therapeutics, Inc. Companies in our database. You can also find out about relevant LogicBio Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record